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Abstract 
The noncovalent complexes between the BlaI protein dimer (wild type and GM2 
mutant) and its double-stranded DNA operator were studied by nanospray mass 
spectrometry and MS/MS. Reproducibility problems in the nanospray single-stage 
MS are emphasized. The relative intensities depend greatly on the shape of the 
capillary tip, and on the capillary-cone distance. This results in difficulties in 
assessing the relative stabilities of the complexes simply from MS spectra of protein-
DNA mixtures. Competition experiments are a better approach to determine relative 
binding affinities. A competition between histidine-tagged BlaIWT (BlaIWTHis) and 
the GM2 mutant revealed that the two proteins have similar affinities for the DNA 
operator, and that they co-dimerize to form heterocomplexes. The low sample 
consumption of nanospray allows MS/MS spectra to be recorded at different collision 
energies for different charge states with 1 µL of sample. The MS/MS experiments on 
the dimers reveals that the GM2 dimer is more kinetically stable in the gas phase than 
the wild type dimer. The MS/MS experiments on the complexes shows that the two 
proteins require the same collision energy to dissociate from the complex. This 
indicates that the rate-limiting step in the monomer loss from the protein-DNA 
complex arises from the breaking of the protein-DNA interface rather than the 
protein-protein interface. The dissociation of the protein-DNA complex proceeds by 
the loss of a highly charged monomer (carrying about two thirds of the total charge 
and one third of the total mass). MS/MS experiments on a heterocomplex also show 
that the two proteins BlaIWTHis and BlaIGM2 have slightly different charge 
distributions in the fragments. This emphasizes the need for better understanding the 
dissociation mechanisms of biomolecular complexes. 
Introduction 
Electrospray ionization mass spectrometry has proven to be extremely useful for the 
study of noncovalent complexes. Several reviews have been dedicated to studies of 
this kind.1-9 It is now commonly accepted that, provided that some experimental 
precautions are taken to minimize non-specific aggregation, the electrospray mass 
spectra reflect the composition of the solution regarding the stoichiometries of the 
observed complexes. It is however more tricky to assess whether the relative 
intensities of the peaks reflect the relative abundances of the corresponding species in 
solution. Different studies on small model systems have been conducted in 
electrospray ionization to test this hypothesis, and several authors have shown that the 
equilibrium binding constants could be determined.10-13 Others have proceeded by 
competition experiments to determine relative binding affinities that correlate well 
with solution data.14-16 
The present work is part of a project which aims to study the complexation of the BlaI 
repressor with its DNA target. The BlaI repressor is a prokaryotic regulator that, in the 
absence of β-lactam antibiotic, prevents the transcription of the blaP gene, encoding 
the Bacillus licheniformis 749/I β-lactamase BlaP.17 BlaI is a protein with 128 amino 
acids composed of two functional domains: a DNA-binding domain located in its N-
Terminal end and a dimerization domain located in its C-Terminal region.18,19 In 
Bacillus licheniformis, BlaI specifically recognises 3 regulatory regions. These 
operators present a symmetry dyad of 23 bp long with the following consensus 
sequence20: 5’-AAAGTATTACATATGTAAGNTTT-3’. Cross linking experiments 
revealed that BlaI is present in the bacterial cell as a dimer, and gel filtration 
experiments revealed that BlaI binds the DNA as a preformed dimer.21 
Several papers have already described the study of protein-DNA complexes by 
electrospray mass spectrometry, either in the negative22-25 or in the positive ion 
mode.26-29 In all these papers the stoichiometries of the complexes were found to 
match the solution-phase behavior. Competition experiments between the specific 
DNA sequence and mutant DNA’s have also shown that only the specific complexes 
were detected by ESI-MS.22-24,26,29 The stability of the complexes in solution as a 
function of the ammonium acetate concentration has been monitored by ESI-MS.22,29 
The stability of the complexes in the gas phase has been studied by in-source CID.26,29 
Kapur et al.29 have addressed the problem of the relative response factors in the ESI-
MS spectra of their complexes, and found that, in their experimental conditions, the 
response of the free protein and the response of the complex were the same within 
experimental error. However, this finding is not supposed to be a general case. 
In contrast to this whole body of literature describing the use of the electrospray 
technique (with flow rates from 0.3 to 10 µL/min), only one paper was found to report 
a study of a protein-DNA complex by nanospray mass spectrometry.30 These authors 
used the method to detect a previously unexpected complex stoichiometry. The main 
advantage of nanospray is the low sample consumption. The use of nanospray to 
study noncovalent biomolecular complexes has been pioneered by Robinson’s 
group.31-38 Nanospray is believed to be more gentle than electrospray for the transfer 
of the ions from the solution to the mass analyzer:34,35 there is no gas flow coaxial to 
the spray, and therefore there are fewer activating collisions in the nanospray source. 
Nanospray has allowed very large assemblies,33,39,40 and even a virus capsid of 2.5 
MDa,41 to be detected intact. Like electrospray, nanospray allows specific complexes 
to be detected.31-38 A competition experiment between peptides for SH2 protein also 
shows a good agreement between calorimetric and nanospray-MS results.34 The 
association or dissociation of protein complexes has also been monitored by 
nanospray-MS.37,42 In particular, the relative proportions of tetramer and monomers of 
transthyretin and mutants are in agreement with the biological activity.31 
The present paper describes a nanospray-Q-TOFMS and MS/MS study of the 
complexes between the repressor protein BlaI (wild type and GM2 mutant: 
Met97Ile/Val98Leu) and its DNA operator. To our knowledge, this is the first MS/MS 


















Plasmids and DNA manipulations 
PET (Novagen) containing the T7 promotor under the control of the lacI repressor, 
was used as a vector for the overexpression of the BlaIWT, BlaIGM2 and BlaIWTHis 
products. The construction of the plasmids PET22BBlaIWT and PET22BBlaIGM2 
was described elsewhere.21 Plasmid PET22BBlaIWTHis was constructed with the 
following protocol: a 400 bp fragment covering the blaI gene was amplified by 
polymerase chain reaction (PCR) using PET22BBlaIWT as template and the 
following oligonucleotides as primers: 5’-
ATACATATGAAAAAAATACCTCAAATCTCTG-3’ (BlaINdeI) and 5’- 
TTACTCGAGTTCCTTCTTTCTGTTCTTATG-3’ (BlaIXhoI).  The amplified 
fragment was ligated to the PGEM-T-Easy plasmid to give the PGEM-T-Easy 
BlaIWT. The identity of the amplified DNA segment was confirmed by determination 
of its nucleotide sequence. PGEM-T-EasyBlaIWT was digested with NdeI and XhoI 
restriction enzymes, and the fragment corresponding to BlaIWT was purified by 
agarose gel electrophoresis and ligated to the PET22B digested with the same 
endonucleases to give the PET22BBlaIWTHis. In this construct, an inframe fusion 
was obtained between the 3’ end of the blaI gene and the PET22B sequence coding 
for the histidine tag, to give BlaI protein with six additional histidine residues at the C 
terminal end. 
 
Protein overexpression and purification 
BlaIWt, BlaIWTHis and BlaIGM2 proteins were prepared by growing Escherichia 
Coli Bl21DE3plys containing the corresponding recombinant PET22B plasmid on LB 
medium supplemented with 100 µg/mL ampicillin and 30 µg/mL chloramphenicol. 
Cells were grown at 37 °C to an A600nm of about 0,7-0,8 and isopropyl β-D-
thiogalactopyranoside (IPTG) was then added to a final concentration of 1 mM. After 
3h, cells were collected by centrifugation (at 9000 g for 20 min) and resuspended in 
the washing buffer (10 mM Tris-HCl pH = 7,5 – NaCl 1%). Cells were then collected 
by centrifugation and resuspended in the lysis buffer (15 mM Tris-HCl pH = 8 – 
10mM MgSO4 – 100 mM KCl – 2.5 mg/L Pefabloc). The cells were disrupted by 
passage through a desintegrator (INCELTECH Z, MODEL) at 20 kpsi. DNA was 
digested by an endonuclease (benzonase, Eurogentec, 5µl/4l cultivation) for 30 min at 
4 °C. Insoluble materials were removed by centrifugation at 14000 rpm for 40 min 
and the resulting supernatant was dialyzed two times against 2l of buffer A (50 mM 
HEPES pH = 7.6 – 1 mM EDTA – glycerol 5 %). The solution was first applied to a 
S-Sepharose Fast Flow equlibrated in buffer A and then eluted at 5 ml/min using 
buffer B (50 mM HEPES pH = 7.6 – 1 mM EDTA – 0.6 M NaCl - glycerol 5 %). The 
BlaI-containing fractions were pooled, dialysed two times against 2 L of buffer C (50 
mM HEPES pH = 7.6 – 1 mM EDTA – 0.2 M NaCl – glycerol 5 %) and then loaded 
onto Hitrap-Heparin-S Sepharose equilibrated with buffer C and eluted at 1mL/min 
using a gradient of 0.2 – 2 M NaCl. The major protein fractions were pooled and 
prepared for MS studies. The final yield of purified (95 % pure) protein was 
approximately 15 mg per litre of cell culture. 
 
MS sample preparation 
Protein. Purified BlaI proteins were prepared for MS analysis by dialysis against a 
buffer containing 150 mM ammonium acetate (NH4OAc) and then concentrated to 25 
µM by using a centricon (Amicon, Brussel, Belgium). Finally, protein solutions were 
desalted by filtration on a Micro Bio-Spin 6 microcolumn (Bio-Rad, Hercules, CA, 
USA) conditioned with ammonium acetate (150 mM). 
DNA Operator. The DNA sequence of the operator duplex used in this work 
represents the perfect palindromic operator recognized by BlaI. Oligonucleotide 5’- 
AAAGTATTACATATGTAATACTTT-3’ (M = 7348 Da) was obtained from 
Eurogentec (Liège, Belgium). The duplex is a dimer of this self-complementary 
oligonucleotide (M = 14696 Da). The duplex is formed by heating the single strand to 
95 °C, followed by overnight cooling. 
Complexes. The complexes were formed by mixing the protein and the DNA operator 
in equimolar (protein/duplex) amounts, and incubating for 2h at room temperature. 
 
Mass Spectrometry 
The nanospray tips were gold-coated glass capillaries (Protana, Odense, DK) that are 
cut manually. The spectrometer was a Q-TOF2 (Micromass, Manchester, UK) 
equipped with the Z-Spray nanoflow source. The source block was heated to 80 °C. 
Note that only the cone was heated and that the nanospray capillary remained cold. A 
voltage of 850 to 1050 V (see text) was applied to produce the spray. The cone 
voltage was set at an optimal value of 40 V for all experiments. This is well below the 
dissociation onset for the complex, and high enough to achieve good ion transmission. 
In the MS/MS mode, argon was used as collision gas. 
Results and Discussion 
MS1 of protein-DNA mixtures 
Initially, our goal was to investigate whether nanospray-MS could give a reliable 
measure of the relative binding affinities of different proteins for DNA, and 
eventually a measure of the absolute binding constants. Therefore it was necessary to 
measure the relative intensities of complex and free DNA or protein in mixtures. We 
first tested the reproducibility of the mass spectra (MS1) for the wild type (BlaIWT) 
mixed with equimolar amounts of DNA operator (double-stranded). Several 
capillaries were made with the same mixture, and spectra were recorded over several 
days. It rapidly appeared that the reproducibility regarding the relative intensities of 
the peaks was poor. To illustrate this point, the two most different spectra among all 
those obtained are displayed in Figure 1. Except for the sodium, content which is 
obviously higher in spectrum (a) than in spectrum (b), the mixtures were prepared 
identically. Spectrum (a) shows a signal corresponding to the free double-stranded 
DNA operator (ds) and to the protein dimer (D), but these peaks do not appear in 
spectrum (b). The MS/MS results (see below) show that these two species cannot 
arise from the dissociation of the complex. The species present in solution are clearly 
sampled in a different way in the two nanospray experiments. 
This is further illustrated in Figure 2. The two spectra were acquired from the same 
capillary, containing equimolar amounts of the BlaI mutant GM2 and DNA. The 
spray was induced, and spectrum (2a) was recorded. Then the spray was stopped, the 
capillary was re-cut, and the spray was restarted. Spectrum (2b) was acquired with 
this second spray from the same capillary. The data obtained clearly show that the 
way in which the capillary is cut is a crucial parameter in the appearance of the mass 
spectrum. In the course of our systematic studies, we also found that two other 
parameters have a dramatic influence on the relative intensities in the spectra: the 
spacing between the capillary and the cone (in the Z-spray configuration), and the 
capillary voltage. These two parameters are linked: the larger the capillary-cone 
distance, the larger the capillary voltage must be in order to maintain a stable spray. 
We found that the larger the capillary-cone distance, the more favored are the species 
of high m/z (data not shown).  
Such a dependence of relative intensities on the position where the plume is sampled 
has already been demonstrated in electrospray.43,44 The present results show that a 
dramatic dependence on the capillary position also occurs in nanospray. They also 
illustrate that in nanospray the mass spectra depend on parameters that are difficult to 
control, like the shape of the capillary tip, which have a large influence on the 
formation of a stable spray in the cone-jet mode. Moreover, it is well known that 
achieving a stable cone-jet mode is extremely difficult for aqueous solutions.45 These 
problems are avoided in electrospray, in which the flow rate is controlled and fixed, 
and a sheath gas regulates the spray formation. It is obvious, by comparing Figure 1 
and Figure 2 that the relative binding affinities of the two variants of BlaI can not be 
reliably ascertained by comparing the relative intensities of the complexes in the 
nanospray mass spectra (MS1).  
 
Competition between wild type and mutant BlaI 
The only way to avoid the reproducibility problem between different capillaries is to 
perform competition experiments between species of similar masses. Here we mixed 
equimolar amounts of BlaIWT and BlaIGM2 with the DNA operator. As BlaIWT and 
BlaIGM2 cannot be distinguished by their masses (4 Da difference), BlaIWT was 
replaced with a mutant bearing a histidine mass tag at the C-terminal-domain, 
BlaIWTHis. Such a modification is supposed not to affect the DNA binding. The 
mass spectrum of the equimolar mixture is shown in Figure 3. Not only the 
homodimer complexes can form, but also a heterodimer complex (WTHis + GM2 + 
dsDNA) forms, despite the fact that the mutation is located in the dimerization 
domain. Furthermore, the relative intensities of the homodimer peaks show that 
BlaIWT has only a slightly higher affinity for the DNA than  BlaIGM2. This was 
impossible to assess from the simple mass spectra of the protein-DNA mixtures only. 
In nanospray mass spectrometry, the competition experiment is an approach that 
allows the confident determination of the relative binding affinities, with not too 
many experimental constraints. 
 
MS/MS 
It is obvious that the great advantage of nanospray is the low sample consumption, 
which allows us to perform MS/MS experiments with only a few picomoles of 
material. To probe the gas-phase stability of the complexes, we performed MS/MS 
experiments on the WT and GM2 protein dimers (Figure 4) and on their complexes 
with the DNA operator (Figures 5 and 6). In all cases, MS/MS was performed by 
automated data acquisition. For each charge state, eight different collision energies 
were used (the cone voltage was maintained at 40 V), and the total duration of 
acquisition was 40 min. For three hours of data acquisition, usually less than 1 µL of 
sample is consumed.  
A great advantage of MS/MS over in-source CID in nanospray is that, in contrast to 
full scan MS1, the MS/MS spectrum does not depend on the spray conditions (shape 
of the capillary, capillary-cone distance, capillary voltage). Sometimes the spray had 
to be re-initiated during the data acquisition, with no effect on the relative intensities 
measured in the MS/MS spectra. 
For BlaI dimers, MS/MS was performed on a 25 µM protein solution, on charge states 
12+ and 11+. For charge state 12+, the relative intensity of the dimer peak did not 
decrease to zero at high energies, but rather levelled off, indicating that either some 
monomer 6+ is isolated together with the dimer12+, or that the dimer12+ dissociates 
into monomer6+. The former hypothesis is more plausible than the latter, due to the 
uneven charge partitioning that is observed for the charge state 11+ (see below). We 
therefore have chosen to discuss the MS/MS behavior of the non-even charge state 
11+, which is unambiguously a dimer. Two fragmentation pathways are observed: (1) 
dimer11+ → monomer7+ + monomer4+ and (2) dimer11+ → monomer8+ + monomer3+. 
The uneven charge separation of these dimers recalls that already observed by 
Versluis et al.46 For both the wild type and the mutant BlaI dimers, the percentage of 
dimer as a function of the collision energy was calculated as follows:  
% Dimer = I(dimer11+) x 100 / (I(dimer11+)+I(mono8+)+I(mono7+))  (1) 
The results are displayed in Figure 4. The GM2 mutant dimer is found to be 
unambiguously more kinetically stable in the gas phase than the WT dimer. The same 
qualitative result was found for the charge state 12+ (not shown). This indicates that 
the mutation in the dimerization domain of the protein increased the gas-phase kinetic 
stability of the GM2 dimer. This probably means that favorable electrostatic 
interactions are created by the mutation in GM2. This does not, however, necessarily 
reflect the relative stabilities in solution, which can be partly due to hydrophobic 
interactions. 
The MS/MS experiment was then conducted on the complexes (dimer + dsDNA) at 
charge states 14+ and 13+. The MS/MS spectra of the complex14+ at 40 eV for the 
WT and the GM2 protein are shown in Figure 5. The major fragment is the 
monomer9+. The complementary fragment (monomer + dsDNA)5+ could be detected 
at high m/z, but with a low relative intensity. The shape of the peak also indicates 
some simultaneous neutral loss, which could not be resolved from the (monomer + 
dsDNA)5+ species. This could be due to depurination of the dsDNA.26,29 For the 
charge state 13+ the two major fragments are the monomers 9+ and 8+. The loss of 
one highly charged monomer (much lower m/z than the parent ion) parallels a feature 
commonly encountered for protein complexes.46-48 This is the first time such behavior 
has been reported for protein-DNA complexes, to our knowledge.  
In order to compare the gas-phase kinetic stability of BlaIWT and BlaIGM2 
complexes with DNA, the percentage of surviving complex, calculated with equation 
2, is plotted against the collision energy. 
% Complex = I(complex) x 100 / {I(complex) + Σ I(mono)}   (2) 
The results are plotted in Figure 6 for the charge states 14+ and 13+. In contrast with 
the MS/MS results for the dimers, there is no difference in the relative collision 
energy dependence of the percentage of surviving complex. As the mutation is located 
in the dimerization domain of BlaI, this indicates that the rate-limiting step in the 
dissociation is likely to imply the opening of the complex at the protein-DNA 
interface rather at the protein-protein interface (dimerization domain).  
We also performed a MS/MS experiment on the heterocomplex (WTHis + GM2 + 
dsDNA)14+. The spectrum recorded at 45 eV is shown in Figure 7. It was hoped that 
the proportion of BlaIWTHis and BlaIGM2 monomers could give, by analogy with 
the kinetic method,49,50 an estimation of the relative affinities for the DNA. The 
results in Figure 7 show that the situation is not so simple: depending on the charge 
state, the relative abundances of the two proteins differ. The BlaIWTHis has a greater 
tendency to accommodate more charges than the GM2 mutant. This was also 
observed in the MS/MS experiments on the heterocomplex at charge state 13+ (not 
shown). This further illustrates the importance of studying the hows and whys of 
charge partitioning upon collision-induced dissociation of multiply charged 
biomolecular complexes.  
 
Conclusion 
In summary, we have studied the complexes between BlaI protein dimers and their 
DNA operators by nanospray mass spectrometry. Reproducibility problems in the 
relative intensities of the complexes were emphasized in MS1 experiments. These are 
attributed to the low spray stability in aqueous solutions. As a consequence, the 
sampling of the ions emitted by nanospray is highly influenced by parameters like the 
shape of the spray tip, the capillary-cone distance, etc… However, MS/MS 
experiments were highly reproducible (the relative intensities did not depend on the 
spray stability), and could be conducted with minimal sample consumption. MS/MS 
allows us to probe the contribution of intermolecular interactions (hydrogen bonds, 
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Nanospray mass spectra (MS1) of an equimolar mixture (25 µM) of BlaIWT and 
double-stranded (ds) DNA. Spectra A and B were recorded with different capillaries. 
C = (WT2 + dsDNA); ds = double-stranded DNA ; ss = single-stranded DNA. 
 
Figure 2. 
Nanospray mass spectra (MS1) of an equimolar mixture (25 µM) of BlaIGM2 and 
double-stranded (ds) DNA. Spectra A and B were recorded with the same capillary. 
Spectrum B was recorded after re-cutting the capillary that was used to record 
spectrum A. C = (GM22 + dsDNA); ss = single-stranded DNA; M = GM2 monomer; 
D = GM2 dimer. 
 
Figure 3. 
Nanospray mass spectrum (MS1) of an equimolar mixture (25-25-25 µM) of 
BlaIGM2, BlaIWTHis and double-stranded DNA (competition experiment). Only the 
region of the complexes (protein dimer + dsDNA) is shown for clarity. Two white 
circles represent the homocomplex (GM22 + dsDNA); two black circles represent the 
homocomplex (WTHis2 + dsDNA); a white and a black circle represent the 
heterocomplex (GM2 + WTHis + dsDNA). 
 
Figure 4. 
Relative intensity of the dimer as a function of the collision energy in nanospray-
MS/MS experiments on the protein dimers (black = WT; white = GM2). The relative 
intensities were calculated using equation (1). 
 
Figure 5. 
Nanospray-MS/MS spectra of the complexes (A) (WT2 + dsDNA)14+ and (B) (GM22 
+ dsDNA)14+ at the same collision energy (40 ev). C = complex; M = protein 
monomer; ds = double-stranded DNA. Note the magnification factor between m/z 
5300 and 6300. 
 
Figure 6. 
Relative intensity of the complex as a function of the collision energy in nanospray-
MS/MS experiments on the protein-DNA complexes (black = WT; white = GM2; 
circles = charge state 14+; triangles = charge state 13+). The relative intensities were 
calculated using equation (2). 
 
Figure 7. 
Nanospray-MS/MS experiment on the heterocomplex (GM2 + WTHis + dsDNA)14+ 
at 45 eV collision energy. C = complex; G = GM2 monomer; W = WTHis monomer. 
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